The HCPLive conference coverage page features articles, videos, and expert-led live coverage from major medical meetings throughout the year.
Non Anthracycline-containing Regimen HER TC Safe for Lower Risk Early Breast Cancer Patients
December 15th 2008Herceptin plus docetaxel/cyclophosphamide (HER TC) adjuvant therapy—a non-anthracycline-containing regimen—was tolerable with acceptable safety for lower risk patients with HER2-positive early breast cancer, according to a large Phase II study.
Researchers Identify Specific Associations Between Cancer Risk and Breast Density
December 15th 2008Previous research indicates that dense breast tissue is a risk factor for breast cancer development. Some studies have suggested that women who have highly dense breasts (≥60%-75% dense tissue) were as much as six times more likely to develop carcinoma of the breast than women whose breasts consisted primarily of fatty tissue.
Technology Can Make Treating Epilepsy Easier
Although the symposium focused on neurosurgery-specific content, it is still important that all neurologists are aware of the technological advancements in imaging, electrophysiology, and brain modeling that are happening all of the time.
First Public Results of the SANTE Trial Announced at AES
Saturday night Robert Fisher, MD, professor of neurology and director of the Stanford Epilepsy Center, presented the first public results of the stimulation of the anterior nucleus of the thalamus in epilepsy (SANTE).
Insights into the Mechanism and Treatment of AF and Other Arrhythmias
This abstract oral session featured several researchers who reviewed (quite quickly) the results of their studies, focused on such topics as spatiotemporal behavior of high dominant frequency, isoproterenol agents, mistakes in the use of amiodarone and anticoagulation management, and 3D transesophageal ultrasound. Highlights of these studies are provided below.